Oaktree Acquisition Corp....

NASDAQ: OACC · Real-Time Price · USD
10.38
0.08 (0.78%)
At close: Aug 18, 2025, 2:28 PM

Oaktree Acquisition III Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q3 2024
Period Ending Mar 31, 2025 Sep 30, 2024
Cash & Equivalents
1.28M n/a
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
195.76M 638.99K
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
n/a n/a
Total Current Assets
1.48M n/a
Property-Plant & Equipment
n/a n/a
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
195.76M 638.99K
Total Assets
197.24M 638.99K
Account Payables
395.69K n/a
Deferred Revenue
n/a n/a
Short-Term Debt
11.82K 109.41K
Other Current Liabilities
n/a 545.75K
Total Current Liabilities
1.06M 662.09K
Long-Term Debt
n/a n/a
Other Long-Term Liabilities
7.02M n/a
Total Long-Term Liabilities
7.02M n/a
Total Liabilities
8.08M 662.09K
Total Debt
11.82K 109.41K
Common Stock
195.68M 503.00
Retained Earnings
-6.52M -48.09K
Comprehensive Income
n/a n/a
Shareholders Equity
189.16M -23.09K
Total Investments
n/a n/a